While it correlates with poor prognosis in pancreatic ductal adenocarcinoma (PDAC), TIMP1 also promotes neutrophil-mediated immune suppression, complicating therapeutic targeting (32). This evidence concerns the gene TIMP1 and pancreatic ductal adenocarcinoma.